Company: DNLI
Filing Date: 2025-05-06
Form Type: 10-Q
Source: 0001714899-25-000105
Chunk: 392

Company: Denali Therapeutics Inc.
Filing Date: 2025-05-06
Form: 10-Q
Item: Part II, Item 6
Chunk 392
---
 Report on Form 10-Q, irrespective of any general incorporation language contained in such filing. #Portions of this exhibit have been omitted pursuant to a request for confidential treatment and this exhibit has been filed separately with the SEC.

97

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. 

 DENALI THERAPEUTICS INC.Date:May 6, 2025By:/s/ Ryan J. WattsRyan J. Watts, Ph.D.President and Chief Executive Officer(Principal Executive Officer)Date:May 6, 2025By:/s/ Alexander O. SchuthAlexander O. Schuth, M.D.Chief Operating and Financial Officer(Principal Financial and Accounting Officer)

98